Perceptions of Generic Drugs in the Pharmacists of Public Hospitals: A Cross-sectional Survey in Hubei Province of China

Abstract

Objective

Generic drugs provide an opportunity for savings in drug expenditure since they are available at a lower cost and do not affect patients’ health. A better understanding of pharmacists’ knowledge, attitudes, and perception can promote the quality use of generic drugs. The objective of this study was to investigate the knowledge, attitudes, and perception of pharmacists from tertiary hospitals in China regarding generic drugs.

Methods

A cross-sectional survey using a postal questionnaire was conducted, which was sent to 200 hospital pharmacists randomly selected from tertiary hospitals in Hubei Province. A total of 125 questionnaires out of 200 were received. Of the respondents, 80 were female and 45 were male.

Results

The majority of respondents (87.2%) could clearly distinguish between original and generic drugs. Pharmacists agreed that generic drugs were less effective (52.8%) and produced more side effects (52%). Fortynine respondents thought that generic drug products were not adequately tested. Approximately 78% and 60% of the pharmacists indicated that generic substitution was not feasible for drugs with narrow therapeutic windows and drugs for critical diseases, respectively. Most of them supported the recommendation of generic drugs based on professional judgment.

Conclusion

Our study showed that a considerable portion of Chinese hospital pharmacists hold negative perceptions of generic drugs. Interventions to improve pharmacists’ knowledge of generic drugs are needed.

Keywords

generic drugs substitution / pharmacist / perceptions

References

[1] ColganS, FaasseK, MartinLR, et al.. Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open, 2015, 5(12): 1-9

[2] MuralidharanG, MicalizziM, SpethJ, et al.. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. Antimicrob Agents Chemother, 2005, 49(1): 220-229

[3] SuzanneD, ColumD, WalterC. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacology and Toxicology, 2013, 14(1): 2-19

[4] HassaliMA, ShafieAA, JamshedS, et al.. Consumers’ views on generic medicines: a review of the literature. Int J Pharm Pract, 2009, 17(2): 79-88

[5] Generic Drugs: Questions and Answers. https://www.fda.gov/Drugs/ResourcesForYou/Consumers/QuestionsAnswers/ucm100100.htm.2017-01-03.

[6] PHARMACPharmaceutical Management Agency Annual Report, 2011, Wellington, Pharmaceutical Management Agency

[7] RougheadEE, KimDS, OngB, et al.. Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price. WHO South East Asia J Public Health, 2018, 7(2): 99-106

[8] KingDR, KanavosP. Encouraging the use of generic medicines: implications for transition economies. Croat Med J, 2002, 43: 462-469

[9] CameronA, Mantel-TeeuwisseAK, LeufkensHG, et al.. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?. Value Health, 2012, 15(5): 664-673

[10] HassaliMA, WongZY, AlrasheedyAA, et al.. Perspectives of physicians practicing in low and middle income countries towards generic medicines: a narrative review. Health Policy, 2014, 117(3): 297-310

[11] BabarZU, GroverP, StewartJ, et al.. Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand. Res Social Adm Pharm, 2011, 7(3): 294-305

[12] MalyJ, DosedelM, KubenaA, et al.. Analysis of pharmacists’ opinions, attitudes and experiences with generic drugs and generic substitution in the Czech Republic. Acta Pol Pharm, 2013, 70(5): 923-931

[13] DrozdowskaA, HermanowskiT. Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland. Int J Clin Pharm, 2016, 38(1): 162-170

[14] DunneSS, ShannonB, CullenW, et al.. Perceptions and attitudes of community pharmacists towards generic medicines. J Manag Care Spec Pharm, 2014, 20(11): 1138-1146

[15] AwaisuA, KheirN, IbrahimMI, et al.. Knowledge, attitudes, and practices of community pharmacists on generic medicines in Qatar. Int J Clin Pharm, 2014, 36(2): 394-404

[16] AutaA, BalaET, ShalkurD. Generic medicine substitution: a cross-sectional survey of the perception of pharmacists in North-Central, Nigeria. Med Princ Pract, 2014, 23(1): 53-58

[17] ZangS, ZhaoM, OuYangJ, et al.. Interpretation of China’s 2017 health expenditure: a latent profile analysis of panel data. BMJ Open, 2020, 10(6): 1-8

[18] GongS, CaiH, DingY, et al.. The availability, price and affordability of antidiabetic drugs in Hubei province, China. Health Policy Plan, 2018, 33(8): 937-947

[19] AlrasheedyA, HassaliMA, StewartK, et al.. Patient knowledge, perceptions, and acceptance of generic medicines: a comprehensive review of the current literature. Patient Intelligence, 2014, 6: 1-29

[20] AllenetB, BarryH. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm World Sci, 2003, 25(5): 197-202

[21] HussainiMA, AlsaffarN, AbdulraheemA. Exploring community pharmacists’ knowledge, perception and experiences towards branded and generic medicines in Kuwait: Highlighting the role of pharmacist. Bull Faculty Pharmacy Cairo Univ, 2018, 56: 109-114

[22] El-DahiyatFA, KayyaliR. Community pharmacists’ perceptions towards generic medicines and their opinions on future generic substitution policy implementation: a descriptive study from Jordan. J Generic Med, 2013, 10(2): 97-104

[23] BabarZU, StewartJ, ReddyS, et al.. An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland. Pharm World Sci, 2010, 32(4): 440-448

[24] VallesJA, BarreiroM, CerezaG, et al.. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy, 2003, 65(3): 269-275

[25] BabarZU, PolwinA, KanSW, et al.. Exploring pharmacists’ opinions regarding PHARMAC’s interventions in promoting brand changes. Res Social Adm Pharm, 2015, 11(1): 96-110

[26] BabarZU, KanSW, ScahillS. Interventions promoting the acceptance and uptake of generic medicines: a narrative review of the literature. Health Policy, 2014, 117(3): 285-296

[27] KirkingDM, GaitherCA, AscioneFJ, et al.. Physicians individual and organizational views on generic medications. J Am Pharm Assoc, 2001, 41: 718-722

[28] OlssonE, SporrongSK. Pharmacists’ experiences and attitudes regarding generic drugs and generic substitution: two sides of the coin. Int J Pharm Pract, 2012, 20(6): 377-383

[29] BradlowJ, CoulterA. Effect of fundholding and indicative prescribing schemes on general practitioners’ prescribing costs. BMJ, 1993, 307(6913): 1186-1189

[30] KalischLM, RougheadEE, GilbertAL. Pharmaceutical brand substitution in Australiadare there multiple switches per prescription?. Aust N Z J Public Health, 2007, 31: 348-352

[31] TokluHZ, DulgerGA, HidirogluS, et al.. Knowledge and attitudes of the pharmacists, prescribers and patients towards generic drug use in Istanbul — Turkey. Pharm Pract (Granada), 2012, 10(4): 199-206

[32] GodmanB, ShrankW, AndersenM, et al.. Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications. Expert Rev Pharmacoecon Outcomes Res, 2010, 10(6): 707-722

[33] KanavosP. Do generics offer significant savings to the UK National Health Service?. Curr Med Res Opin, 2007, 23(1): 105-116

[34] Al-GedadiNA, HassaliMA. Pharmacists’ Views on Generic Medicines: A Review of the Literature. J Generic Med, 2008, 5(3): 209-218

[35] AllenetB, BarryH. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm World Sci, 2003, 25(5): 197-202

[36] SharradAK, HassaliMA. Consumer perception on generic medicines in Basrah, Iraq: preliminary findings from a qualitative study. Res Social Adm Pharm, 2011, 7(1): 108-112

[37] NgoSN, StupansI, McKinnonRA. Generic substitution in the treatment of epilepsy: patient attitudes and perceptions. Epilepsy Behav, 2013, 26(1): 64-66